NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $93 | +1.1% | 1,015 | 0.0% | 0.06% | +6.7% |
| Q4 2022 | $92 | -99.9% | 1,015 | 0.0% | 0.06% | -10.4% |
| Q3 2022 | $77,000 | 0.0% | 1,015 | +15.5% | 0.07% | +21.8% |
| Q4 2021 | $77,000 | +133.3% | 879 | +114.9% | 0.06% | +89.7% |
| Q3 2021 | $33,000 | -10.8% | 409 | 0.0% | 0.03% | +3.6% |
| Q2 2021 | $37,000 | +5.7% | 409 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $35,000 | -32.7% | 409 | -25.6% | 0.03% | -30.0% |
| Q4 2020 | $52,000 | -63.1% | 550 | -66.0% | 0.04% | -57.9% |
| Q3 2020 | $141,000 | +98.6% | 1,619 | +114.7% | 0.10% | +150.0% |
| Q4 2019 | $71,000 | +1.4% | 754 | -5.9% | 0.04% | -19.1% |
| Q3 2019 | $70,000 | -29.3% | 801 | -26.2% | 0.05% | -34.7% |
| Q2 2019 | $99,000 | -1.0% | 1,086 | +3.6% | 0.07% | +2.9% |
| Q1 2019 | $100,000 | +61.3% | 1,048 | +44.2% | 0.07% | +11.1% |
| Q4 2018 | $62,000 | +12.7% | 727 | +12.9% | 0.06% | +21.2% |
| Q3 2018 | $55,000 | – | 644 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |